Publish Date: 1 May 2021 - 19:39

By: Iman Hamikhah

3rd clinical trial phase of jointly-produced Cov-19 vaccine

HAMEDAN, May 01 (MNA) – The 3rd clinical trial phase of joint anti-Covid-19 vaccine made by the Iranian Pasteur Institute and Cuban Finlay Institute began on Saturday morning in Hamedan Medical Sciences University in western Iran.

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

آغاز فاز سوم کارآزمایی واکس3rd clinical trial phase of jointly-produced Cov-19 vaccine

3rd clinical trial phase of jointly-produced Cov-19 vaccine

Tags